Clinical Trial Update: Multiple Dose Study Of PF-05231023 In Obese Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose study of PF-05231023 in obese adults (including those with Type 2 Diabetes Mellitus) was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-05231023

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: TERMINATED | Results posted: 2014-09-17